Ensign Peak Advisors’s Integra LifeSciences IART Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Hold |
19,912
| – | – | ﹤0.01% | 1666 |
|
|
2025
Q1 | $438K | Hold |
19,912
| – | – | ﹤0.01% | 1579 |
|
|
2024
Q4 | $452K | Hold |
19,912
| – | – | ﹤0.01% | 1626 |
|
|
2024
Q3 | $362K | Hold |
19,912
| – | – | ﹤0.01% | 1663 |
|
|
2024
Q2 | $580K | Hold |
19,912
| – | – | ﹤0.01% | 1559 |
|
|
2024
Q1 | $706K | Sell |
19,912
-1,004
| -5% | -$35.6K | ﹤0.01% | 1520 |
|
|
2023
Q4 | $911K | Hold |
20,916
| – | – | ﹤0.01% | 1439 |
|
|
2023
Q3 | $799K | Hold |
20,916
| – | – | ﹤0.01% | 1364 |
|
|
2023
Q2 | $860K | Hold |
20,916
| – | – | ﹤0.01% | 1382 |
|
|
2023
Q1 | $1.2M | Buy |
20,916
+550
| +3% | +$31.6K | ﹤0.01% | 1094 |
|
|
2022
Q4 | $1.14M | Sell |
20,366
-5,100
| -20% | -$286K | ﹤0.01% | 1058 |
|
|
2022
Q3 | $1.08M | Hold |
25,466
| – | – | ﹤0.01% | 1027 |
|
|
2022
Q2 | $1.38M | Hold |
25,466
| – | – | ﹤0.01% | 965 |
|
|
2022
Q1 | $1.64M | Hold |
25,466
| – | – | ﹤0.01% | 954 |
|
|
2021
Q4 | $1.71M | Sell |
25,466
-34,960
| -58% | -$2.34M | ﹤0.01% | 1024 |
|
|
2021
Q3 | $4.14M | Hold |
60,426
| – | – | 0.01% | 733 |
|
|
2021
Q2 | $4.12M | Buy |
60,426
+3,900
| +7% | +$266K | 0.01% | 730 |
|
|
2021
Q1 | $3.91M | Sell |
56,526
-10,617
| -16% | -$733K | 0.01% | 736 |
|
|
2020
Q4 | $4.36M | Hold |
67,143
| – | – | 0.01% | 661 |
|
|
2020
Q3 | $3.17M | Hold |
67,143
| – | – | 0.01% | 759 |
|
|
2020
Q2 | $3.16M | Hold |
67,143
| – | – | 0.01% | 751 |
|
|
2020
Q1 | $3M | Buy |
67,143
+7,176
| +12% | +$321K | 0.01% | 665 |
|
|
2019
Q4 | $3.5M | Buy |
+59,967
| New | +$3.5M | 0.01% | 770 |
|